Thank you for your inquiry regarding CMS2v11: Preventive Care and Screening: Screening for Depression and Follow-Up Plan. Per the measure specification, documented follow-up for a positive depression screening must include one or more of the following: Referral to a provider for additional evaluation and assessment to formulate a follow-up plan for a positive depression screen Pharmacological interventions Other interventions or follow-up for the diagnosis or treatment of depression Examples of a follow-up plan include but are not limited to: Referral to a provider or program for further evaluation for depression, for example, referral to a psychiatrist, psychiatric nurse practitioner, psychologist, clinical social worker, mental health counselor, or other mental health service such as family or group therapy, support group, depression management program, or other service for treatment of depression Other interventions designed to treat depression such as behavioral health evaluation, psychotherapy, pharmacological interventions, or additional treatment options Per the measure specification, the "Adolescent Depression Medications" (2.16.840.1.113883.3.526.3.1567), "Adult Depression Medications" (2.16.840.1.113883.3.526.3.1566), "Referral for Adolescent Depression" (2.16.840.1.113883.3.526.3.1570), "Referral for Adult Depression" (2.16.840.1.113883.3.526.3.1571), "Follow Up for Adolescent Depression" (2.16.840.1.113883.3.526.3.1569), and "Follow Up for Adult Depression" (2.16.840.1.113883.3.526.3.1568) value sets include codes that identify acceptable follow-up plans that would meet numerator criteria for follow-up related to a positive depression screening. The guidance provides a limited list of examples, and these examples reflect a subset of all of the options found in the value sets for appropriate follow-up. You can review codes included in each value set on the Value Set Authority Center (VSAC) website at https://vsac.nlm.nih.gov .

Good afternoon, Our project team received the inquiry below from an external partner regarding the following measure: Preventative Care and Screening: Screening for Depression and Follow-Up (CMS2v12). We would appreciate any insight your team is able to provide on this inquiry.